Posttransplant infections in the tropical countries

Artificial Organs

Volumn 26, Issue 9, 2002, Pages 770-777

  Jha, Vivekanand ^a   Chugh, Kirpal S ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b 601   (India)

Author keywords

Cyclosporine; Fungal infections; Transplant infections; Transplantation; Tropical infections; Tuberculosis

Indexed keywords

DISEASE CONTROL; FUNGI; TROPICS; VIRUSES;

CONDITION; CYCLOSPORINE; FUNGAL INFECTION; HOT AND HUMID CLIMATE; RENAL TRANSPLANT RECIPIENTS; TRANSPLANT INFECTION; TRANSPLANTATION; TROPICAL COUNTRIES; TROPICAL INFECTIONS; TUBERCULOSIS;

DIAGNOSIS;

ALLOPURINOL; AMPHOTERICIN B; ANTIMALARIAL AGENT; ANTIMONY; ANTIRETROVIRUS AGENT; CIPROFLOXACIN; CLOTRIMAZOLE; CYCLOSPORIN A; ETHAMBUTOL; FLUCONAZOLE; GAMMA INTERFERON; GRISEOFULVIN; ISONIAZID; IVERMECTIN; LAMIVUDINE; NYSTATIN; PAROMOMYCIN; PENTAMIDINE; PREDNISOLONE; PYRAZINAMIDE; PYRROLE DERIVATIVE; RIFAMPICIN; STIBOGLUCONATE SODIUM; TERBINAFINE; TIABENDAZOLE;

ALLOGRAFT; ARTICLE; ASPERGILLOSIS; BACTERIAL INFECTION; CANDIDIASIS; CHRONIC LIVER DISEASE; CLIMATE; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG EFFICACY; EARLY DIAGNOSIS; ENDEMIC DISEASE; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY TRANSPLANTATION; LUNG LAVAGE; MALARIA; MORTALITY; MUCORMYCOSIS; MYCOSIS; NEMATODIASIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RECIPIENT; RISK FACTOR; TROPICS; TUBERCULOSIS; VIRUS INFECTION; VIRUS REPLICATION; VISCERAL LEISHMANIASIS;

ASPERGILLUS; BACTERIA (MICROORGANISMS); CANDIDA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS; MUCOR; PROTEA;

EID: 0036051310     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2002.07069.x     Document Type: Article

References (69)

1. Differences in the care of ESRD patients worldwide: Required resources and future outlook
2. Infectious complications following renal transplantation
3. Infectious disease complications of renal transplantation
4. Infection in the renal transplant recipient
5. Infections after kidney transplantation
6. Declining incidence of wound infection in cadaveric renal transplant recipient
7. Infectious complications in the first 100 days after renal transplantation
8. Infections in renal transplant recipients in Israel
9. Infection in kidney transplantation recipients in Indonesia
10. Tropical infections after renal transplantation
11. Liver disease in tropical renal transplant patients: An autopsy study
12. High mortality in systemic fungal infections following renal transplantation in third-world countries
13. High mortality among recipients of bought living-unrelated donor kidneys
14. Commercially motivated renal transplantation: Results in 540 patients transplanted in India
15. Living unrelated (paid) kidney transplantation in third-world countries: High risk of complications besides the ethical problem
16. Terminal infections in renal transplant patients in a tropical environment
17. Successful management of pulmonary tuberculosis in renal allograft recipients in a single center
18. Renal transplantation with pulmonary infection
19. The high incidence of tuberculosis among renal transplant recipients in India
20. Outcome of living-related donor renal allografts in hepatitis C antibody-positive recipients
21. Mycobacterial infection in renal transplant recipients
22. Tuberculosis after renal transplantation: Experience of one Turkish center
23. Tuberculosis and renal transplantation - Observations from an endemic area of tuberculosis
24. Cyclosporine immunosuppression and mycobacterial infections
25. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients
26. Mycobacterial infection after renal transplantation - Report of 14 cases and review of the literature
27. Disseminated tuberculosis in a renal transplant recipient presenting as a non-healing skin ulcer. A case report
28. Bone tuberculosis: An unusual case of mycobacterial infection in a renal allograft recipient
29. Laryngeal tuberculosis in renal transplant recipients
30. Renal allograft tuberculosis
31. The experimental induction of localized skeletal tuberculous lesions and their accesibility to streptomycin
32. Granulomatous tubulointerstitial nephritis in the renal allograft
33. The use of cyclosporine modifies the clinical and histopathological presentation of tuberculosis after renal transplantation
34. A double-blind randomized controlled trial of primary isoniazid prophylaxis in dialysis and transplant patients
35. Mycobacteriun tuberculosis infections after renal transplantation
36. Tuberculosis in renal transplant recipients
37. Spectrum of dermatological lesions in renal allograft recipients in a tropical environment
38. Dermatological manifestations in renal transplant recipients
39. Esophageal candidiasis after renal transplantation: Comparative study in patients on different immunosuppressive protocols
40. Pulmonary mucormycosis presenting as fatal massive hemoptysis in a renal transplant recipient
41. Isolated zygomycosis in a bought living unrelated kidney transplant
42. Cryptococcosis in renal allograft recipients
43. Systemic fungal infections in renal transplant recipients at Chennai, India
44. Retinitis following disseminated cryptococcosis in a renal allograft recipient. Efficacy of oral fluconazole
45. The impact of cyclosporine therapy on the occurrence of infection in the renal transplant recipients
46. Factors in an outbreak of Pneumocystis carinii in a transplant unit
47. Transmission of Pneumocystis carinii from AIDS patients to other immunocompromised patients: A cluster of Pneumocystis carinii pneumonia in renal transplant recipients
48. The emergence of Pneumocystis carinii pneumonia in renal transplant patients in a south Indian hospital
49. Disseminated histoplasmosis 19 years after renal transplantation. Case report and review of literature
50. Subcutaneous phaeohyphomycosis in a renal transplant recipient: A case report and review of the literature
51. Cytomegalovirus infection in renal transplant recipients in India
52. Epidemiology of cytomegalovirus infections
53. Cytomegalovirus infection in a seroendemic renal transplant population, a longitudinal study of virological markers
54. Hepatitis B infection in a dialysis unit in South India
55. A study of hepatitis B surface antigen positive patients on hemodialysis and following transplantation
56. Long-term survival in living related donor renal allograft recipients with hepatitis B infection
57. Clinical course of concomitant HBV and HCV infection in renal allograft recipients
58. HBV and HCV infection in kidney transplant recipients
59. Viral hepatitis B and HCV infection among renal transplant patients in Brazil
60. Role of molecular techniques in the detection of HBV DNA & HCV RNA among renal transplant recipients in India
61. Clinicopathologic course of hepatitis B infection in surface antigen carriers following living-related renal transplantation
62. High prevalence of hepatitis G viremia among kidney transplant patients in Thailand
63. Treatment of chronic hepatitis B with lamivudine in renal transplant recipients
64. Results on preemptive or prophylactic treatment of lamivudine in HBsAg (+) renal allograft recipients: Comparison with salvage treatment after hepatic dysfunction with HBV recurrence
65. Prevalence of HIV infection in a dialysis unit
66. Visceral leishmaniasis (Kala-Azar) in transplant recipients: Case report and review
67. Visceral leishmaniasis in a renal transplant recipient: Diagnostic and therapeutic problems
68. Visceral leishmaniasis without fever in a kidney transplant recipient
69. Posttransplant malaria